Key facts
- This page summarizes Christopher M. Smith's Form 4 filing for Ortho Clinical Diagnostics Holdings plc.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jan 2022, 15:23.
Christopher M. Smith - 03 Jan 2022 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc
- Reporting relationship
- Chairman and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 03 Jan 2022
- Net transaction value
- -$853,800
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2022, 15:23:58 UTC
- Prior SEC filing
- 04 Aug 2021
- Next SEC filing
- 01 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael A. Schlesinger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher M. Smith filed Form 4 for Ortho Clinical Diagnostics Holdings plc on 05 Jan 2022.
Change
- Previous filing in this sequence was filed on 04 Aug 2021.
- Current net transaction value: -$853,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCDX
transaction
Ordinary Shares, $0.00001 par value
Options Exercise
- Transaction value
- $1,256,000
- Shares
- +100,000
- Change %
- +27%
- Price
- $12.56
- Shares after
- 467,360
- Date
- 03 Jan 2022
- Ownership
- Direct
OCDX
transaction
Ordinary Shares, $0.00001 par value
Sale
- Transaction value
- $2,109,800
- Shares
- -100,000
- Change %
- -21%
- Price
- $21.10
- Shares after
- 367,360
- Date
- 03 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCDX
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -9.7%
- Price
- $0.000000
- Shares after
- 935,710
- Date
- 03 Jan 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares, $0.00001 par value
- Underlying amount
- 100,000
- Exercise price
- $12.56
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
Footnote F3
Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.4000
Footnote F4
The stock option vests in three equal annual installments beginning on September 9, 2020.